drugset / Trial / NCT00760318

Keppra for Cervical Dystonia

NCT00760318

Phase 2 Terminated 17 enrolled University of South Florida
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate if there is an improved response in CD symptoms when Keppra is used as adjunctive therapy to Botox.

Timeline

Start
2005-11
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 3000 mg Oral

Indications